CG Asset Management’s Core Laboratories CLB Stock Holding History

CG Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,200	Closed	-$768K	–	133
2016 Q2	$768K	Buy	+6,200	New	+$748K	0.31%	81
2014 Q2	–	Sell	-2,600	Closed	-$516K	–	134
2014 Q1	$516K	Buy	+2,600	New	+$491K	0.23%	93

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

CG Asset Management's CLB Position: Q3 2016 in Review

CG Asset Management sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 6,200 shares — an estimated $768K sold.

CG Asset Management first reported a position in CLB in Q1 2014 and held it in 2 quarters. The position peaked at $768K in Q2 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

CG Asset Management reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
CG Asset Management sold 6,200 Core Laboratories shares in Q3 2016, an estimated $768K.
CG Asset Management first reported a position in Core Laboratories in Q1 2014 and held it in 2 quarters.
CG Asset Management's Core Laboratories position peaked at $768K in Q2 2016.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on CG Asset Management's 13F filing for Q3 2016, filed 2 Nov 2016.